The Peter Attia Drive

Snapshot · The Peter Attia Drive

#399 ‒ The evolution of Alzheimer's disease and dementia care: how early detection, personalized treatment, new therapies, and a multimodal approach are changing the landscape | Gayatri Devi, M.D.

Explore episode Jul 13, 2026

Where this was said

Multimodal treatment approach

At 1:16:18 · chapter starts 1:15:00

Prior to the monoclonal antibody era, Gayatri Devi was already applying a rich multimodal toolkit inspired by the HIV treatment model: a personalized cocktail of drugs targeting different mechanisms. She continues to use cholinesterase inhibitors like donepezil and galantamine, memantine (an NMDA antagonist that reduces signal-to-noise ratio in neurotransmission), and valacyclovir for patients with herpetic neuroinflammation risk. Since 2008, she has used transcranial magnetic stimulation off-label, targeting the dorsolateral prefrontal cortex, Broca's area, and the precuneus using neuronavigation guided by each patient's own MRI to maintain specific neural circuits. GLP-1 agonists are now part of the toolkit for appropriate patients. Peter Attia observes that the pattern he sees across chronic diseases — from atherosclerosis to cancer — is that early, sustained treatment over years moves the needle far more than late, aggressive intervention, and he laments that the right clinical trials for early, low-dose anti-amyloid therapy haven't been funded.

Similar snapshots

Health & Fitness
Pipe broke → hydrogen sulfide studio air

Tortilla Face · Aug 10, 2026

A broken pipe filled the Bad Friends studio with what the hosts identified as hydrogen sulfide — microscopic fecal aeroparticles — that the crew denied smelling.